Role of galectin-3 in vascular calcification

Area of Science:

• Cardiovascular Biology
• Biochemistry
• Pathology

Background:

• Vascular calcification is a pathological process involving hydroxyapatite crystal deposition in vessel walls.
• It is a critical feature of atherosclerosis, type 2 diabetes, and chronic kidney disease, posing significant health risks.
• Early detection and management of vascular calcification are crucial for cardiovascular risk stratification and patient outcomes.

Purpose of the Study:

• To elucidate the role and mechanisms of galectin-3 in vascular calcification.
• To explore galectin-3's involvement in vascular calcification under various pathological conditions.
• To highlight galectin-3 as a potential biomarker and therapeutic target.

Main Methods:

• Review of existing literature on vascular calcification and galectins.
• Analysis of preclinical and association studies implicating galectin-3.
• Examination of signaling pathways involved in galectin-3-mediated calcification.

Main Results:

• Galectin-3 is implicated in vascular calcification and vascular intimal calcification (VIC).
• Galectin-3's role is linked to key signaling pathways including Wnt/β-catenin, NF-κB, and ERK1/2.
• Evidence suggests galectin-3 is involved in calcification under atherosclerosis, diabetes, and CKD.

Conclusions:

• Galectin-3 plays a significant role in the pathogenesis of vascular calcification.
• Understanding galectin-3 mechanisms can lead to improved diagnostic and therapeutic strategies.
• Targeting galectin-3 may offer a novel approach to managing vascular calcification and its associated diseases.